| cerebellar granule cell precursor tangential migration | GO:0021935 | 1 | 0.923 | |
| guanosine containing compound catabolic process | GO:1901069 | 144 | 0.559 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.481 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.476 | |
| primary neural tube formation | GO:0014020 | 95 | 0.433 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.429 | |
| gtp catabolic process | GO:0006184 | 143 | 0.404 | |
| positive regulation of synaptic growth at neuromuscular junction | GO:0045887 | 1 | 0.402 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.399 | |
| negative regulation of protein phosphorylation | GO:0001933 | 126 | 0.375 | |
| semaphorin plexin signaling pathway involved in bone trabecula morphogenesis | GO:1900220 | 2 | 0.361 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.357 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.351 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.350 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.349 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.337 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.336 | |
| regulation of cell migration | GO:0030334 | 219 | 0.333 | |
| neural tube closure | GO:0001843 | 90 | 0.332 | |
| branchiomotor neuron axon guidance | GO:0021785 | 7 | 0.331 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.312 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.305 | |
| regulation of synaptic growth at neuromuscular junction | GO:0008582 | 4 | 0.305 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.305 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.285 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.275 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.273 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.271 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.269 | |
| semaphorin plexin signaling pathway | GO:0071526 | 21 | 0.267 | |
| regulation of ras gtpase activity | GO:0032318 | 88 | 0.262 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.262 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.257 | |
| chemorepulsion of branchiomotor axon | GO:0021793 | 1 | 0.255 | |
| regulation of ras protein signal transduction | GO:0046578 | 114 | 0.253 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.246 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.245 | |
| positive regulation of neuron projection development | GO:0010976 | 79 | 0.244 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.241 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.232 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.231 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.230 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.226 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.226 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.223 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.223 | |
| positive regulation of gtp catabolic process | GO:0033126 | 85 | 0.220 | |
| axonogenesis | GO:0007409 | 274 | 0.219 | |
| positive regulation of gtpase activity | GO:0043547 | 85 | 0.217 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.216 | |
| organelle localization | GO:0051640 | 179 | 0.215 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.211 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.210 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.209 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.208 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.207 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.207 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.206 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.205 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.203 | |
| neural tube development | GO:0021915 | 160 | 0.203 | |
| facial nerve structural organization | GO:0021612 | 10 | 0.201 | |
| semaphorin plexin signaling pathway involved in neuron projection guidance | GO:1902285 | 6 | 0.200 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.197 | |
| regulation of gtp catabolic process | GO:0033124 | 113 | 0.196 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.195 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.193 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.193 | |
| postganglionic parasympathetic nervous system development | GO:0021784 | 2 | 0.192 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.190 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.189 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.187 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.185 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.183 | |
| compound eye development | GO:0048749 | 1 | 0.179 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.179 | |
| amine metabolic process | GO:0009308 | 45 | 0.177 | |
| regulation of cell motility | GO:2000145 | 236 | 0.176 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.173 | |
| vagus nerve morphogenesis | GO:0021644 | 2 | 0.169 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.167 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.166 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.163 | |
| gtp metabolic process | GO:0046039 | 144 | 0.163 | |
| positive regulation of nucleotide catabolic process | GO:0030813 | 88 | 0.153 | |
| guanosine containing compound metabolic process | GO:1901068 | 144 | 0.153 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.152 | |
| regulation of rho gtpase activity | GO:0032319 | 58 | 0.149 | |
| positive regulation of purine nucleotide catabolic process | GO:0033123 | 88 | 0.149 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.146 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.146 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.145 | |
| t cell activation | GO:0042110 | 289 | 0.142 | |
| trigeminal nerve morphogenesis | GO:0021636 | 6 | 0.141 | |
| regulation of purine nucleotide catabolic process | GO:0033121 | 122 | 0.140 | |
| semaphorin plexin signaling pathway involved in axon guidance | GO:1902287 | 6 | 0.138 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.138 | |
| chemotaxis | GO:0006935 | 247 | 0.138 | |
| hindbrain tangential cell migration | GO:0021934 | 2 | 0.137 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.137 | |
| developmental maturation | GO:0021700 | 193 | 0.133 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.130 | |
| dichotomous subdivision of terminal units involved in salivary gland branching | GO:0060666 | 5 | 0.130 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.129 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.128 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.128 | |
| inflammatory response | GO:0006954 | 244 | 0.126 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.119 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.118 | |
| cell adhesion | GO:0007155 | 329 | 0.117 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.117 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.114 | |
| synaptic transmission | GO:0007268 | 329 | 0.113 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.113 | |
| mapk cascade | GO:0000165 | 281 | 0.111 | |
| neuron migration | GO:0001764 | 122 | 0.109 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.106 | |
| regulation of nucleoside metabolic process | GO:0009118 | 130 | 0.104 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.103 | |
| neural tube formation | GO:0001841 | 108 | 0.103 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.103 | |
| vagus nerve development | GO:0021564 | 3 | 0.102 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.102 | |
| glossopharyngeal nerve morphogenesis | GO:0021615 | 4 | 0.101 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 114 | 0.101 | |
| epithelial tube formation | GO:0072175 | 130 | 0.100 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.100 | |
| heart morphogenesis | GO:0003007 | 178 | 0.100 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.100 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.098 | |
| detection of stimulus | GO:0051606 | 84 | 0.095 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.094 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.092 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.092 | |
| trunk neural crest cell migration | GO:0036484 | 4 | 0.090 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.087 | |
| regulation of vasculature development | GO:1901342 | 88 | 0.087 | |
| rhythmic process | GO:0048511 | 174 | 0.085 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.084 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 151 | 0.084 | |
| somitogenesis | GO:0001756 | 69 | 0.083 | |
| cell division | GO:0051301 | 120 | 0.082 | |
| muscle contraction | GO:0006936 | 101 | 0.082 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.081 | |
| appendage development | GO:0048736 | 166 | 0.081 | Fly |
| axon guidance | GO:0007411 | 141 | 0.080 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.079 | |
| sympathetic neuron projection extension | GO:0097490 | 4 | 0.079 | |
| tube closure | GO:0060606 | 91 | 0.079 | |
| rap protein signal transduction | GO:0032486 | 3 | 0.077 | |
| detection of abiotic stimulus | GO:0009582 | 60 | 0.075 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.074 | |
| detection of external stimulus | GO:0009581 | 61 | 0.073 | |
| positive regulation of ras gtpase activity | GO:0032320 | 65 | 0.073 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.073 | |
| positive regulation of rho gtpase activity | GO:0032321 | 41 | 0.072 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.069 | |
| regulation of fat cell differentiation | GO:0045598 | 81 | 0.068 | |
| regulation of cytoskeleton organization | GO:0051493 | 122 | 0.068 | |
| negative regulation of cell motility | GO:2000146 | 61 | 0.067 | |
| tube formation | GO:0035148 | 140 | 0.066 | |
| facial nerve development | GO:0021561 | 11 | 0.066 | |
| negative regulation of extrinsic apoptotic signaling pathway | GO:2001237 | 45 | 0.064 | |
| neuron projection guidance | GO:0097485 | 141 | 0.064 | |
| response to light stimulus | GO:0009416 | 135 | 0.064 | |
| cranial nerve development | GO:0021545 | 41 | 0.064 | |
| substrate dependent cell migration | GO:0006929 | 18 | 0.064 | |
| protein processing | GO:0016485 | 163 | 0.063 | |
| retina development in camera type eye | GO:0060041 | 119 | 0.063 | |
| regulation of nucleotide catabolic process | GO:0030811 | 122 | 0.062 | |
| pallium development | GO:0021543 | 120 | 0.062 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 114 | 0.061 | |
| sympathetic neuron projection guidance | GO:0097491 | 4 | 0.060 | |
| regulation of cell size | GO:0008361 | 72 | 0.060 | |
| parasympathetic nervous system development | GO:0048486 | 19 | 0.059 | |
| mucopolysaccharide metabolic process | GO:1903510 | 25 | 0.059 | |
| dendritic spine organization | GO:0097061 | 26 | 0.059 | |
| gonadotrophin releasing hormone neuronal migration to the hypothalamus | GO:0021828 | 3 | 0.059 | |
| ameboidal type cell migration | GO:0001667 | 128 | 0.058 | |
| negative regulation of kinase activity | GO:0033673 | 81 | 0.058 | |
| cranial nerve structural organization | GO:0021604 | 13 | 0.058 | |
| glycoprotein biosynthetic process | GO:0009101 | 89 | 0.058 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.058 | |
| positive regulation of nucleoside metabolic process | GO:0045979 | 91 | 0.058 | |
| negative regulation of transferase activity | GO:0051348 | 85 | 0.057 | |
| regulation of axon extension | GO:0030516 | 43 | 0.057 | |
| response to radiation | GO:0009314 | 165 | 0.056 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.056 | |
| renal system development | GO:0072001 | 225 | 0.055 | |
| anatomical structure arrangement | GO:0048532 | 20 | 0.054 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.054 | |
| hypothalamus gonadotrophin releasing hormone neuron development | GO:0021888 | 4 | 0.053 | |
| calcium ion transport | GO:0006816 | 159 | 0.053 | |
| rac protein signal transduction | GO:0016601 | 13 | 0.052 | |
| t cell differentiation | GO:0030217 | 174 | 0.052 | |
| smooth muscle cell migration | GO:0014909 | 10 | 0.052 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.052 | Mouse |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.051 | |
| kidney development | GO:0001822 | 213 | 0.051 | |
| regulation of neuron migration | GO:2001222 | 22 | 0.051 | |
| limb development | GO:0060173 | 166 | 0.050 | |
| motor neuron axon guidance | GO:0008045 | 26 | 0.050 | |
| erythrocyte differentiation | GO:0030218 | 88 | 0.050 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.050 | |
| regulation of intracellular transport | GO:0032386 | 159 | 0.050 | |
| anterior commissure morphogenesis | GO:0021960 | 6 | 0.050 | |
| sensory perception | GO:0007600 | 245 | 0.050 | |
| trigeminal nerve structural organization | GO:0021637 | 6 | 0.049 | |
| cell migration in hindbrain | GO:0021535 | 16 | 0.049 | |
| trigeminal nerve development | GO:0021559 | 10 | 0.049 | |
| ossification | GO:0001503 | 216 | 0.048 | |
| lymphocyte proliferation | GO:0046651 | 164 | 0.048 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.048 | |
| branching involved in salivary gland morphogenesis | GO:0060445 | 26 | 0.048 | |
| regionalization | GO:0003002 | 337 | 0.048 | Fly |
| neural precursor cell proliferation | GO:0061351 | 121 | 0.048 | |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.047 | |
| negative regulation of osteoblast proliferation | GO:0033689 | 4 | 0.047 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.047 | |
| embryonic epithelial tube formation | GO:0001838 | 130 | 0.047 | |
| cell communication by chemical coupling | GO:0010643 | 2 | 0.047 | |
| appendage morphogenesis | GO:0035107 | 149 | 0.046 | Fly |
| neuroblast proliferation | GO:0007405 | 49 | 0.046 | |
| regulation of rho protein signal transduction | GO:0035023 | 71 | 0.046 | |
| epithelial cell migration | GO:0010631 | 63 | 0.046 | |
| spermatogenesis | GO:0007283 | 284 | 0.046 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.045 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.045 | |
| regulation of inflammatory response | GO:0050727 | 147 | 0.045 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.045 | |
| cranial nerve morphogenesis | GO:0021602 | 26 | 0.044 | |
| negative regulation of neuron differentiation | GO:0045665 | 101 | 0.043 | |
| nephron epithelium morphogenesis | GO:0072088 | 68 | 0.043 | |
| positive regulation of binding | GO:0051099 | 49 | 0.043 | |
| preganglionic parasympathetic nervous system development | GO:0021783 | 17 | 0.043 | |
| locomotory behavior | GO:0007626 | 195 | 0.043 | |
| regulation of tight junction assembly | GO:2000810 | 2 | 0.042 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.042 | |
| epithelial cell development | GO:0002064 | 159 | 0.042 | |
| establishment or maintenance of microtubule cytoskeleton polarity | GO:0030951 | 1 | 0.041 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.041 | |
| forebrain development | GO:0030900 | 302 | 0.041 | |
| cell growth | GO:0016049 | 130 | 0.041 | |
| synapse assembly | GO:0007416 | 56 | 0.041 | |
| detection of visible light | GO:0009584 | 14 | 0.041 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.041 | |
| axon target recognition | GO:0007412 | 4 | 0.041 | |
| immune response regulating signaling pathway | GO:0002764 | 125 | 0.041 | |
| regulation of peptidyl tyrosine phosphorylation | GO:0050730 | 93 | 0.041 | |
| regulation of endopeptidase activity | GO:0052548 | 89 | 0.041 | |
| positive regulation of cell morphogenesis involved in differentiation | GO:0010770 | 72 | 0.040 | |
| regulation of circadian sleep wake cycle | GO:0042749 | 3 | 0.040 | |
| angiogenesis | GO:0001525 | 201 | 0.040 | |
| hindbrain development | GO:0030902 | 128 | 0.040 | |
| cerebral cortex tangential migration using cell axon interactions | GO:0021824 | 3 | 0.040 | |
| oxidation reduction process | GO:0055114 | 342 | 0.040 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.040 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.040 | |
| limb morphogenesis | GO:0035108 | 149 | 0.039 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.039 | |
| peripheral nervous system development | GO:0007422 | 53 | 0.039 | |
| glial cell differentiation | GO:0010001 | 131 | 0.039 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.039 | |
| positive regulation of rac gtpase activity | GO:0032855 | 14 | 0.039 | |
| regulation of exocytosis | GO:0017157 | 61 | 0.039 | |
| negative regulation of hydrolase activity | GO:0051346 | 71 | 0.039 | |
| neural crest cell migration involved in autonomic nervous system development | GO:1901166 | 5 | 0.038 | |
| dichotomous subdivision of an epithelial terminal unit | GO:0060600 | 11 | 0.038 | |
| regulation of binding | GO:0051098 | 111 | 0.038 | |
| positive regulation of synapse assembly | GO:0051965 | 18 | 0.037 | |
| stem cell differentiation | GO:0048863 | 268 | 0.037 | |
| circadian rhythm | GO:0007623 | 114 | 0.037 | |
| cellular response to lipid | GO:0071396 | 145 | 0.037 | |
| positive regulation of immune effector process | GO:0002699 | 107 | 0.036 | |
| dendritic spine maintenance | GO:0097062 | 4 | 0.036 | |
| neural retina development | GO:0003407 | 41 | 0.036 | |
| positive regulation of cell projection organization | GO:0031346 | 95 | 0.036 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.036 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.036 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.036 | |
| oocyte axis specification | GO:0007309 | 2 | 0.036 | |
| cell recognition | GO:0008037 | 83 | 0.035 | |
| skin development | GO:0043588 | 220 | 0.035 | Fly |
| dendrite development | GO:0016358 | 115 | 0.035 | Fly |
| regulation of peptidase activity | GO:0052547 | 96 | 0.034 | |
| gonad development | GO:0008406 | 141 | 0.034 | |
| skeletal system development | GO:0001501 | 356 | 0.034 | |
| regulation of cell shape | GO:0008360 | 39 | 0.034 | |
| regulation of protein localization | GO:0032880 | 231 | 0.033 | |
| carbohydrate biosynthetic process | GO:0016051 | 74 | 0.033 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.033 | |
| intracellular protein transport | GO:0006886 | 204 | 0.033 | |
| negative regulation of growth | GO:0045926 | 99 | 0.033 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.033 | |
| regulation of cell growth | GO:0001558 | 91 | 0.033 | |
| tissue migration | GO:0090130 | 68 | 0.033 | |
| synapse organization | GO:0050808 | 125 | 0.033 | |
| facial nerve morphogenesis | GO:0021610 | 11 | 0.032 | |
| schwann cell proliferation | GO:0014010 | 2 | 0.032 | |
| maternal determination of anterior posterior axis embryo | GO:0008358 | 2 | 0.032 | |
| regulation of myeloid cell differentiation | GO:0045637 | 96 | 0.032 | |
| tissue homeostasis | GO:0001894 | 115 | 0.032 | |
| stem cell proliferation | GO:0072089 | 117 | 0.032 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.032 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.032 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.032 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.032 | |
| oocyte anterior posterior axis specification | GO:0007314 | 2 | 0.032 | |
| glycoprotein metabolic process | GO:0009100 | 116 | 0.032 | |
| lateral inhibition | GO:0046331 | 1 | 0.032 | |
| gland development | GO:0048732 | 330 | 0.032 | |
| positive regulation of protein autophosphorylation | GO:0031954 | 4 | 0.031 | |
| regulation of ion transport | GO:0043269 | 215 | 0.031 | |
| regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043281 | 62 | 0.031 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.031 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.031 | |
| hypothalamic tangential migration using cell axon interactions | GO:0021856 | 3 | 0.031 | |
| positive regulation of lymphocyte proliferation | GO:0050671 | 70 | 0.031 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.031 | |
| hippocampus development | GO:0021766 | 52 | 0.031 | |
| forebrain generation of neurons | GO:0021872 | 63 | 0.031 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.030 | |
| establishment of vesicle localization | GO:0051650 | 81 | 0.030 | |
| actin filament organization | GO:0007015 | 113 | 0.030 | |
| ossification involved in bone maturation | GO:0043931 | 12 | 0.030 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.030 | |
| muscle fiber development | GO:0048747 | 76 | 0.030 | |
| regulation of extrinsic apoptotic signaling pathway | GO:2001236 | 77 | 0.030 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.030 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.030 | |
| outflow tract morphogenesis | GO:0003151 | 53 | 0.030 | |
| central nervous system neuron development | GO:0021954 | 67 | 0.030 | |
| bone development | GO:0060348 | 120 | 0.030 | |
| erk1 and erk2 cascade | GO:0070371 | 77 | 0.029 | |
| telencephalon development | GO:0021537 | 186 | 0.029 | |
| multicellular organism growth | GO:0035264 | 161 | 0.029 | |
| asymmetric neuroblast division | GO:0055059 | 1 | 0.029 | |
| brown fat cell differentiation | GO:0050873 | 36 | 0.029 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.029 | |
| somite development | GO:0061053 | 81 | 0.029 | |
| fat cell differentiation | GO:0045444 | 160 | 0.029 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.029 | |
| gonad morphogenesis | GO:0035262 | 1 | 0.029 | |
| maintenance of location | GO:0051235 | 89 | 0.029 | |
| negative regulation of neuron projection development | GO:0010977 | 50 | 0.028 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.028 | |
| retina morphogenesis in camera type eye | GO:0060042 | 45 | 0.028 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.028 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.028 | |
| immune effector process | GO:0002252 | 321 | 0.028 | |
| positive regulation of phosphatidylinositol 3 kinase signaling | GO:0014068 | 20 | 0.028 | |
| negative regulation of cell migration | GO:0030336 | 59 | 0.028 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.028 | |
| signal transduction by p53 class mediator | GO:0072331 | 51 | 0.028 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.027 | |
| digestive tract development | GO:0048565 | 190 | 0.027 | |
| facioacoustic ganglion development | GO:1903375 | 3 | 0.027 | |
| sympathetic nervous system development | GO:0048485 | 22 | 0.027 | |
| regulation of axon guidance | GO:1902667 | 13 | 0.027 | |
| positive regulation of smooth muscle cell migration | GO:0014911 | 4 | 0.027 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.027 | |
| regulation of phosphatidylinositol 3 kinase signaling | GO:0014066 | 30 | 0.027 | |
| immune response activating signal transduction | GO:0002757 | 116 | 0.027 | |
| t cell receptor signaling pathway | GO:0050852 | 46 | 0.027 | |
| monosaccharide metabolic process | GO:0005996 | 106 | 0.026 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.026 | |
| forebrain neuron differentiation | GO:0021879 | 52 | 0.026 | |
| forebrain neuron development | GO:0021884 | 30 | 0.026 | |
| defense response to other organism | GO:0098542 | 197 | 0.026 | |
| blood circulation | GO:0008015 | 195 | 0.026 | |
| regulation of wnt signaling pathway | GO:0030111 | 123 | 0.026 | |
| regulation of synaptic vesicle transport | GO:1902803 | 13 | 0.026 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.026 | |
| ensheathment of neurons | GO:0007272 | 76 | 0.026 | |
| negative regulation of chemotaxis | GO:0050922 | 11 | 0.026 | |
| regulation of circadian sleep wake cycle sleep | GO:0045187 | 3 | 0.026 | |
| positive regulation of secretion | GO:0051047 | 130 | 0.026 | |
| protein import into nucleus | GO:0006606 | 95 | 0.026 | |
| limbic system development | GO:0021761 | 72 | 0.026 | |
| immunoglobulin production | GO:0002377 | 73 | 0.026 | |
| oocyte construction | GO:0007308 | 2 | 0.025 | |
| response to nutrient levels | GO:0031667 | 109 | 0.025 | |
| positive regulation of thymocyte migration | GO:2000412 | 2 | 0.025 | |
| bone maturation | GO:0070977 | 13 | 0.025 | |
| epidermis development | GO:0008544 | 187 | 0.025 | Fly |
| cellular carbohydrate metabolic process | GO:0044262 | 119 | 0.025 | |
| urogenital system development | GO:0001655 | 261 | 0.025 | |
| cellular response to lipopolysaccharide | GO:0071222 | 77 | 0.025 | |
| positive regulation of myeloid cell differentiation | GO:0045639 | 43 | 0.025 | |
| positive regulation of cell migration | GO:0030335 | 109 | 0.025 | |
| aminoglycan metabolic process | GO:0006022 | 34 | 0.024 | |
| adaptive immune response | GO:0002250 | 155 | 0.024 | |
| regulation of lyase activity | GO:0051339 | 13 | 0.024 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.024 | |
| cellular homeostasis | GO:0019725 | 240 | 0.024 | |
| transmembrane transport | GO:0055085 | 412 | 0.024 | |
| exocrine system development | GO:0035272 | 45 | 0.024 | |
| glial cell development | GO:0021782 | 54 | 0.024 | |
| hypothalamus cell differentiation | GO:0021979 | 8 | 0.024 | |
| cation transport | GO:0006812 | 399 | 0.024 | |
| striated muscle contraction | GO:0006941 | 45 | 0.024 | |
| purine containing compound biosynthetic process | GO:0072522 | 70 | 0.024 | |
| positive regulation of peptidyl tyrosine phosphorylation | GO:0050731 | 61 | 0.024 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.024 | |
| negative regulation of cell size | GO:0045792 | 3 | 0.024 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.023 | |
| cation homeostasis | GO:0055080 | 212 | 0.023 | |
| leukocyte mediated immunity | GO:0002443 | 174 | 0.023 | |
| leukocyte proliferation | GO:0070661 | 172 | 0.023 | |
| autonomic nervous system development | GO:0048483 | 43 | 0.023 | |
| jak stat cascade | GO:0007259 | 42 | 0.023 | |
| regulation of cysteine type endopeptidase activity | GO:2000116 | 65 | 0.023 | |
| negative regulation of cell activation | GO:0050866 | 111 | 0.023 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.023 | |
| response to vitamin d | GO:0033280 | 3 | 0.023 | |
| regulation of system process | GO:0044057 | 200 | 0.023 | |
| endocardial cell differentiation | GO:0060956 | 4 | 0.023 | |
| single organism cell adhesion | GO:0098602 | 156 | 0.023 | |
| segmentation | GO:0035282 | 93 | 0.023 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.023 | |
| negative regulation of axon guidance | GO:1902668 | 8 | 0.022 | |
| positive regulation of leukocyte differentiation | GO:1902107 | 86 | 0.022 | |
| striated muscle cell development | GO:0055002 | 125 | 0.022 | |
| regulation of t cell activation | GO:0050863 | 170 | 0.022 | |
| response to growth factor | GO:0070848 | 198 | 0.022 | |
| cerebral cortex development | GO:0021987 | 86 | 0.022 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.022 | |
| macromolecule glycosylation | GO:0043413 | 55 | 0.022 | |
| activation of adenylate cyclase activity | GO:0007190 | 4 | 0.022 | |
| regulation of protein binding | GO:0043393 | 60 | 0.022 | |
| phosphatidylinositol mediated signaling | GO:0048015 | 41 | 0.022 | |
| regulation of ossification | GO:0030278 | 112 | 0.022 | |
| regulation of smooth muscle cell migration | GO:0014910 | 6 | 0.022 | |
| macromolecule deacylation | GO:0098732 | 37 | 0.022 | |
| regulation of dendritic spine development | GO:0060998 | 22 | 0.022 | |
| myeloid cell homeostasis | GO:0002262 | 114 | 0.022 | |
| inositol lipid mediated signaling | GO:0048017 | 41 | 0.022 | |
| positive regulation of cell motility | GO:2000147 | 116 | 0.022 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.022 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.021 | |
| negative regulation of myeloid cell differentiation | GO:0045638 | 38 | 0.021 | |
| positive regulation of cytoskeleton organization | GO:0051495 | 49 | 0.021 | |
| ventral trunk neural crest cell migration | GO:0036486 | 4 | 0.021 | |
| anatomical structure maturation | GO:0071695 | 49 | 0.021 | |
| chromatin organization | GO:0006325 | 206 | 0.021 | |
| compartment pattern specification | GO:0007386 | 4 | 0.021 | |
| male sex differentiation | GO:0046661 | 109 | 0.021 | |
| nucleotide biosynthetic process | GO:0009165 | 78 | 0.021 | |
| positive regulation of macroautophagy | GO:0016239 | 3 | 0.021 | |
| positive regulation of reactive oxygen species biosynthetic process | GO:1903428 | 2 | 0.021 | |
| transmission of nerve impulse | GO:0019226 | 76 | 0.021 | |
| development of primary female sexual characteristics | GO:0046545 | 73 | 0.021 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.021 | |
| synaptic vesicle localization | GO:0097479 | 59 | 0.021 | |
| positive regulation of proteolysis | GO:0045862 | 85 | 0.021 | |
| developmental cell growth | GO:0048588 | 84 | 0.020 | |
| ribonucleotide biosynthetic process | GO:0009260 | 59 | 0.020 | |
| endothelial cell migration | GO:0043542 | 44 | 0.020 | |
| germ cell development | GO:0007281 | 185 | 0.020 | |
| response to peptide hormone | GO:0043434 | 127 | 0.020 | |
| response to peptide | GO:1901652 | 136 | 0.020 | |
| regulation of defense response | GO:0031347 | 233 | 0.020 | |
| glycosylation | GO:0070085 | 62 | 0.020 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.020 | |
| cyclic nucleotide metabolic process | GO:0009187 | 59 | 0.020 | |
| establishment or maintenance of cytoskeleton polarity | GO:0030952 | 2 | 0.020 | |
| negative regulation of proteolysis | GO:0045861 | 74 | 0.020 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.020 | |
| negative regulation of cell morphogenesis involved in differentiation | GO:0010771 | 48 | 0.020 | |
| substrate dependent cerebral cortex tangential migration | GO:0021825 | 3 | 0.020 | |
| establishment of organelle localization | GO:0051656 | 122 | 0.020 | |
| leukocyte migration | GO:0050900 | 124 | 0.020 | |
| negative regulation of cell growth | GO:0030308 | 44 | 0.020 | |
| forebrain cell migration | GO:0021885 | 58 | 0.020 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.020 | |
| regulation of transmembrane transport | GO:0034762 | 128 | 0.020 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.019 | |
| protein maturation | GO:0051604 | 176 | 0.019 | |
| negative regulation of endopeptidase activity | GO:0010951 | 44 | 0.019 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.019 | |
| spermatid differentiation | GO:0048515 | 115 | 0.019 | |
| peptidyl tyrosine phosphorylation | GO:0018108 | 143 | 0.019 | |
| positive regulation of reactive oxygen species metabolic process | GO:2000379 | 11 | 0.019 | |
| regulation of secretion | GO:0051046 | 274 | 0.019 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.019 | |
| kidney epithelium development | GO:0072073 | 121 | 0.019 | |
| g protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger | GO:0007187 | 55 | 0.019 | |
| canonical wnt signaling pathway | GO:0060070 | 130 | 0.019 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.019 | |
| negative regulation of axon extension | GO:0030517 | 19 | 0.019 | |
| pyramidal neuron differentiation | GO:0021859 | 9 | 0.019 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.019 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.019 | |
| detection of stimulus involved in sensory perception | GO:0050906 | 44 | 0.019 | |
| negative regulation of calcium ion dependent exocytosis | GO:0045955 | 3 | 0.019 | |
| nerve development | GO:0021675 | 67 | 0.019 | |
| cellular response to extracellular stimulus | GO:0031668 | 81 | 0.019 | |
| negative regulation of map kinase activity | GO:0043407 | 34 | 0.019 | |
| regulation of phospholipid biosynthetic process | GO:0071071 | 3 | 0.019 | |
| central nervous system neuron differentiation | GO:0021953 | 162 | 0.019 | |
